{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:22:29Z","timestamp":1795040549929,"version":"4.10.2"},"reference-count":31,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The dose of trimethoprim-sulfamethoxazole (TMP-SMX) for the treatment of\n            <jats:named-content content-type=\"genus-species\">Pneumocystis<\/jats:named-content>\n            pneumonia (PCP) in patients without human immunodeficiency virus (HIV) infection has not been verified. The aim of this study was to investigate the efficacy and toxicity of a low-dose TMP-SMX regimen in such patients. A retrospective study was conducted in four hospitals. We reviewed the medical records of patients with PCP but not HIV (non-HIV-PCP) who were treated with TMP-SMX between 2003 and 2016. The patients were divided into conventional-dose (TMP, 15 to 20 mg\/kg\/day) and low-dose (TMP, &lt;15 mg\/kg\/day) groups after patients who received high-dose (TMP, &gt;20 mg\/kg\/day) treatment were excluded. Grouping was done according to a correction dose, which was based on renal function. Eighty-two patients had non-HIV-PCP. The numbers of patients who received high-, conventional-, and low-dose treatments were 5, 36, and 41, respectively. Kaplan-Meier analysis for death associated with PCP showed no statistically significant difference in survival rates between the conventional- and low-dose groups. Ninety-day cause-specific mortality rates were 25.0% and 19.5% in the conventional-dose and low-dose groups (\n            <jats:italic>P<\/jats:italic>\n            = 0.76), respectively. Adverse events that were graded as \u22653 according to the Common Terminology Criteria for Adverse Events (version 4.0) (National Cancer Institute, 2010) were 41.7% and 17.1% in the conventional-dose and low-dose groups (\n            <jats:italic>P<\/jats:italic>\n            = 0.02), respectively. Moreover, vomiting (\n            <jats:italic>P<\/jats:italic>\n            = 0.03) and a decrease in platelet count (\n            <jats:italic>P<\/jats:italic>\n            = 0.03) occurred more frequently in the conventional-dose group. Treatment of non-HIV-PCP with low-dose or conventional-dose TMP-SMX produces comparable survival rates; however, the low-dose regimen is better tolerated and associated with fewer adverse effects.\n          <\/jats:p>","DOI":"10.1128\/aac.01173-17","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:40:28Z","timestamp":1505176828000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":34,"title":["A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection"],"prefix":"10.1128","volume":"61","author":[{"given":"Makoto","family":"Kosaka","sequence":"first","affiliation":[{"name":"First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhito","family":"Ushiki","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ikuyama","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagano Municipal Hospital, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Shinonoi General Hospital, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Hachiya","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Suwa Red Cross Hospital, Suwa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hanaoka","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833a3967"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.3.712"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032588"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/140.5.1204"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.0702"},{"issue":"4","key":"e_1_3_1_7_2","first-page":"1","article-title":"Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan JE","year":"2009","unstructured":"Kaplan JE BensonC HolmesKK BrooksJT PauA MasurH, Centers for Disease Control and Prevention (CDC), National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America. 2009. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep58(RR-4):1\u2013207.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcma.2016.01.007"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365540903214256"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-015-0851-1"},{"key":"e_1_3_1_11_2","volume-title":"National Cancer Institute","author":"National Cancer Institute","year":"2010","unstructured":"National Cancer Institute. 2010. Common terminology criteria for adverse events (CTCAE), version 4.0. National Cancer Institute, National Institutes of Health, Bethesda, MD. https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf."},{"key":"e_1_3_1_12_2","first-page":"147","article-title":"Trimethoprim-sulfamethoxazole","volume":"58","author":"Cockerill FR","year":"1983","unstructured":"Cockerill FR III EdsonRS. 1983. Trimethoprim-sulfamethoxazole. Mayo Clin Proc58:147\u2013153.","journal-title":"Mayo Clin Proc"},{"key":"e_1_3_1_13_2","volume-title":"The Sanford guide to antimicrobial therapy","author":"Gilbert DN","year":"2016","unstructured":"Gilbert DN EliopoulosGM ChambersHF SaagMS (ed). 2016. The Sanford guide to antimicrobial therapy, 46th ed. Antimicrobial Therapy, Inc., Sperryville, VA.","edition":"46"},{"key":"e_1_3_1_14_2","first-page":"382","article-title":"Dosage regimen adjustments in renal impairment","volume":"7","author":"Giusti DL","year":"1973","unstructured":"Giusti DL HaytonWL. 1973. Dosage regimen adjustments in renal impairment. Drug Intell Clin Pharm7:382\u2013387.","journal-title":"Drug Intell Clin Pharm"},{"key":"e_1_3_1_15_2","first-page":"47","article-title":"Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole","volume":"112","author":"Hughes WT","year":"1975","unstructured":"Hughes WT FeldmanS SanyalSK. 1975. Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole. Can Med Assoc J112:47\u201350.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-76"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-0857-z"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-006-0149-4"},{"key":"e_1_3_1_19_2","first-page":"114","article-title":"Pneumocystis carinii pneumonia among patients with neoplastic disease","volume":"7","author":"Sepkowitz KA","year":"1992","unstructured":"Sepkowitz KA . 1992. Pneumocystis carinii pneumonia among patients with neoplastic disease. Semin Respir Infect7:114\u2013121.","journal-title":"Semin Respir Infect"},{"key":"e_1_3_1_20_2","first-page":"246","article-title":"Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases","volume":"21","author":"Godeau B","year":"1994","unstructured":"Godeau B Coutant-PerronneV Le Thi HuongD GuillevinL MagadurG De BandtM DellionS RossertJ RostokerG PietteJC. 1994. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol21:246\u2013251.","journal-title":"J Rheumatol"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes244"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.5.1295"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/2110-5820-4-13"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A188"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91152-9"},{"key":"e_1_3_1_26_2","first-page":"553","article-title":"Evaluation of plasma (1\u21923)-beta-d-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections","volume":"35","author":"Mori T","year":"1997","unstructured":"Mori T IkemotoH MatsumuraM YoshidaM InadaK EndoS ItoA WatanabeS YamaguchiH MitsuyaM KodamaM TaniT YokotaT KobayashiT KambayashiJ NakamuraT MasaokaT TeshimaH YoshinagaT KohnoS HaraK MiyazakiS. 1997. Evaluation of plasma (1\u21923)-beta-d-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clin Chem Clin Biochem35:553\u2013560.","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1467"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/605579"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.1680"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05267-11"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709751"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01173-17","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01173-17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:44:25Z","timestamp":1645476265000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01173-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1128\/AAC.01173-17"],"URL":"https:\/\/doi.org\/10.1128\/aac.01173-17","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"2017-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01173-17"}}